Via Christi to conduct search for CEO, president after Korsmo steps down

Nicholas Leider | | Health Exec | Management

Jeff Korsmo, president and CEO of Via Christi Health, has announced he has accepted a position with Essentia Health in Duluth, Minn. He had been leading the company for more than four years.

Based in Wichita, Kan., and representing the state’s largest provider of healthcare services, Via Christi fully integrated with Ascension Health in 2013, with Korsmo playing an integral role in the transition. He also led efforts to expand Medicaid in Kansas. He was instrumental in creating a joint venture with Mercy to provide primary care to residents in Pittsburg, Kan.

Todd Conkin, COO of Via Christi, will serve as interim president and CEO while the firm conducts a national search for its new leader. Conklin has been with Via Christi since October 2015, serving in both operational and financial executive roles.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.